Burning Rock Biotech Limited (ADR)
General ticker "BNR" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $6.8M (TTM average)
Burning Rock Biotech Limited (ADR) follows the US Stock Market performance with the rate: 43.3%.
Estimated limits based on current volatility of 7.0%: low 28.25$, high 32.53$
Factors to consider:
- Total employees count: 4 as of 2020
- Current price 180.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.43$, 11.12$]
- 2025-12-31 to 2026-12-31 estimated range: [3.65$, 11.42$]
Financial Metrics affecting the BNR estimates:
- Negative: with PPE of -3.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -18.24 <= 0.04
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 65.61 > 64.17
- Positive: -4.41 < Investing cash flow per share per price, % of -0.87
- Positive: Industry inventory ratio change (median), % of -0.84 <= -0.18
Short-term BNR quotes
Long-term BNR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY563.24MM | CNY537.43MM | CNY515.82MM |
| Operating Expenses | CNY1,543.64MM | CNY1,206.76MM | CNY873.38MM |
| Operating Income | CNY-980.41MM | CNY-669.32MM | CNY-357.56MM |
| Non-Operating Income | CNY11.16MM | CNY18.02MM | CNY16.82MM |
| R&D Expense | CNY421.87MM | CNY347.02MM | CNY232.29MM |
| Income(Loss) | CNY-969.25MM | CNY-651.30MM | CNY-340.74MM |
| Taxes | CNY1.99MM | CNY2.39MM | CNY5.88MM |
| Profit(Loss)* | CNY-971.23MM | CNY-653.69MM | CNY-346.63MM |
| Stockholders Equity | CNY1,158.34MM | CNY768.41MM | CNY580.83MM |
| Inventory | CNY130.32MM | CNY69.02MM | CNY53.76MM |
| Assets | CNY1,587.47MM | CNY1,040.00MM | CNY885.30MM |
| Operating Cash Flow | CNY-456.81MM | CNY-255.78MM | CNY-92.26MM |
| Capital expenditure | CNY62.03MM | CNY9.38MM | CNY5.98MM |
| Investing Cash Flow | CNY-7.46MM | CNY-9.30MM | CNY-4.41MM |
| Financing Cash Flow | CNY-86.24MM | CNY-48.83MM | CNY-0.07MM |
| Earnings Per Share** | CNY-93.47 | CNY-63.84 | CNY-33.67 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.